american healthcare reit inc - AHR
AHR
Close Chg Chg %
53.66 1.35 2.52%
Closed Market
55.01
+1.35 (2.52%)
Volume: 4.86M
Last Updated:
Jul 2, 2026, 3:59 PM EDT
Company Overview: american healthcare reit inc - AHR
AHR Key Data
| Open $54.05 | Day Range 53.83 - 55.09 |
| 52 Week Range 35.54 - 55.09 | Market Cap $11.38B |
| Shares Outstanding 206.72M | Public Float 205.03M |
| Beta 0.78 | Rev. Per Employee N/A |
| P/E Ratio 95.32 | EPS $0.58 |
| Yield 181.69% | Dividend $0.25 |
| EX-DIVIDEND DATE Jun 30, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 4.51M |
AHR Performance
| 1 Week | 7.92% | ||
| 1 Month | 15.92% | ||
| 3 Months | 14.45% | ||
| 1 Year | 48.48% | ||
| 5 Years | N/A |
AHR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
13
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 58.231 | |
| Number of Ratings | 13 | Current Quarters Estimate | 0.153 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 0.57 | |
| Last Quarter’s Earnings | 0.14 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.42 | Next Fiscal Year Estimate | 0.814 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 5 | 5 | 5 |
| Mean Estimate | 0.15 | 0.15 | 0.57 | 0.81 |
| High Estimates | 0.16 | 0.18 | 0.61 | 0.90 |
| Low Estimate | 0.13 | 0.13 | 0.51 | 0.69 |
| Coefficient of Variance | 9.05 | 12.63 | 7.09 | 9.75 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 12 | 12 | 10 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 0 | 0 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for American Healthcare Reit Inc - AHR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for American Healthcare Reit Inc - AHR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 9, 2026 | Brian S. Peay Chief Financial Officer | 181,354 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 9, 2026 | Brian S. Peay Chief Financial Officer | 177,700 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $48.09 per share | 8,545,593.00 |
| Apr 9, 2026 | Brian S. Peay Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 9, 2026 | Danny Prosky Director | 355,065 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 9, 2026 | Danny Prosky Director | 346,469 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $48.09 per share | 16,661,694.21 |
| Apr 9, 2026 | Danny Prosky Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |